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Abstract: The occurrence and fate of pharmaceuticals in the aquatic environment is recognized
as one of the emerging issues in environmental chemistry. Conventional wastewater treatment
plants (WWTPs) are not designed to remove pharmaceuticals (and their metabolites) from domestic
wastewaters. The treatability of pharmaceutical compounds in WWTPs varies considerably depending
on the type of compound since their biodegradability can differ significantly. As a consequence,
they may reach the aquatic environment, directly or by leaching of the sludge produced by these
facilities. Currently, the technologies under research for the removal of pharmaceuticals, namely
membrane technologies and advanced oxidation processes, have high operation costs related to
energy and chemical consumption. When chemical reactions are involved, other aspects to consider
include the formation of harmful reaction by-products and the management of the toxic sludge
produced. Research is needed in order to develop economic and sustainable treatment processes,
such as bioremediation and biosorption. The use of low-cost materials, such as biological matrices
(e.g., algae and fungi), has advantages such as low capital investment, easy operation, low operation
costs, and the non-formation of degradation by-products. An extensive review of existing research on
this subject is presented.
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1. Introduction
The growth of world population, the promotion of health and better living conditions, and the rise
of average life expectancy were accompanied by an increase in the consumption of pharmaceuticals,
which are excreted in their original form or as metabolites and collected by the sewage system of
urban wastewaters; they are not completely removed by wastewater treatment plants (WWTPs).
Their occurrence in the aquatic environment is creating polluting pressure on aquatic ecosystems
and is recognized as one of the emerging problems in the last decade [1]. The development of
analytical techniques (such as gas chromatography mass spectrometry and liquid chromatography
mass spectrometry) enabled the detection and quantification of a broad range of pharmaceuticals
(and their metabolites) in environmental matrices [2]. Although they occur at extremely low levels
(ranging from µg·L−1 to ng·L−1 or even lower), it is known that their presence in the environment is
a potential hazard to public health [3–6].
The release of pharmaceuticals into the aquatic environment is not yet subject to regulation.
In Europe, the “Water Framework Directive 2000/60/EC” introduced a strategy for water protection [7].
However, since the water situation in the several European Union (EU) countries was, and still is,
different, it was necessary to proceed with adjustments to the original “Water Framework Directive”.
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In fact, one year after its publication, Decision 2455/2001/EC of the European Parliament and of the
Council of 20 November 2001 established that each European Union member state should create,
until 2009, a program of environmental protection measures for each of its hydrographic regions. A list of
33 priority substances in the field of water policy was also established, which includes pharmaceuticals.
The revision and update of this list is done at least every four years, this may lead to the inclusion of
new priority compounds, or removal, depending on the level of risk they pose [8]. Later, the “Directive
on Environmental Quality Standards” (Directive 2008/105/EC) amended some environmental quality
standards in the field of water policy and also established 11 new substances to be identified as priority
substances or priority hazardous substances [9]. The Directive 2013/39/EU and Implementing Decision
2015/495 incorporated new substances, totalizing 45, implementing the first so-called watchlist. A few
pharmaceuticals (diclofenac, erythromycin, clarithromycin, and azithromycin), as well as synthetic and
natural hormones (estrone, 17β-estradiol, and 17α-ethinylestradiol), were included, and they should be
carefully monitored by the Member States in order to set their environmental quality standards [10,11].
In its last review, five substances or groups of substances were removed, among them diclofenac,
and three new substances were included, among them amoxicillin and ciprofloxacin. This is consistent
with the European One Health Action Plan against Antimicrobial Resistance, which supports the
use of the watchlist to improve knowledge and to evaluate the risks to human and animal health
posed by the presence of antimicrobials in the environment. This review resulted in the publication of
the second watchlist in 2018 (of the Commission Implementing Decision 2018/840 [12]. Also, in the
United States, the Environmental Protection Agency (EPA) included 12 pharmaceuticals, personal care
products, and endocrine disrupting compounds in a list in order to evaluate their related occurrence
and safety risks. Therefore, is expected that, in the near future, legal limits will be established for the
concentration of pharmaceuticals in WWTP discharges.
Indeed, pharmaceuticals are introduced into the environment (Figure 1) mainly through the
discharge of treated effluents from conventional WWTPs, via domestic and hospital wastewaters,
directly or by leaching of the sludge produced by these facilities, or through discharges of the
pharmaceutical industry [13–15], as well as veterinary facilities where pharmaceuticals are widely
used in livestock production for disease prevention and growth promotion [16–18].
The most frequently detected classes of pharmaceuticals in wastewaters are antibiotics,
antiepileptics, antiphlogistics, X-ray contrast media, lipid-regulators, β-blockers, and tranquillizers [19].
Most of these compounds have high solubility, low hydrophobicity, and often negative charge at
neutral pH (acidic compounds); these properties add more difficulties to their treatment [20]. WWTPs
were not specifically designed to completely remove pharmaceuticals [21,22]. Removal efficiencies
can vary from negligible to 100% depending on the compound [23]. The majority of compounds are
removed in a percentage of less than 50%, which is related to the structure of the compounds [20].
Many physico-chemical and biological treatments were tested by WWTPs, but none of them are able
to efficiently remove them [24]. Tertiary treatments, such as membrane technologies and advanced
oxidation processes, usually play a more active role in the removal of these micropollutants than
primary and secondary treatments [5,25]. However, they have many drawbacks in terms of energy
requirement, large use of chemicals, and formation of undesired and harmful by-products [26].
To overcome these drawbacks, the scientific community focused its attention on the development
of eco-friendly, economically viable and comparatively less expensive technologies [27]. Biological
tertiary treatments of wastewaters are efficient, less expensive, and more eco-friendly than other
technologies. The use of certain microorganisms gained importance in applied environmental
microbiology. Fungi and algae-based treatments were pointed out as promising technologies for
the remediation of pharmaceuticals. In this article, special attention is given to studies addressing
pharmaceutical removal with fungi and algae via bioremediation and/or biosorption mechanisms
(Figure 2).
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Figure 2. Mechanisms of pharmaceutical removal with fungi and algae.
2. Bioremediation
Bioremediation is a biological treatment that involves the use of microorganisms and their enzymes to
convert recalcitrant and xenobiotic contaminants to less toxic forms and, therefore, short lifetimes in the
environment or even their complete mineralization (the end-products are essentially carbon dioxide and
water) [28]. Bioremediation of organic compounds was studied in more detail at the laboratory level, with the
metabolic pathways of degradation known for some pharmaceutical compounds [29,30]. The process
is influenced by environmental, physical, and chemical factors, namely, the stereochemistry, toxicity,
and concentration of the contaminant, efficiency of the microbial strain, conditions during degradation
(e.g., pH and temperature), retention time, presence of other compounds, and their concentration [31].
Some of bioremediation’s advantages are as follows: it is accepted as a safe process, transforms
pollutants instead f simply moving them from one medium to another [32], and presents lower costs
when compared to the other technologies [33]. Although bioreme i pro es o be promising
ch ice, research is needed to overcome some drawbacks of the process, which are the incomplete
transformation, the limitation to biodegradable compounds, and the requirement of the selection and
use of different microorganisms with specific metabolism for the different pollutants. Some of these
disadvantages can be overcome through the use of genetically modified microorganisms [34].
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2.1. Mycoremediation
Fungi (“mikes” from Greek) are eukaryotic organisms that include microorganisms such as molds,
yeasts, and mushrooms. Some fungi are chemoheterotrophic organisms, being parasitic or saprophytic.
Some are unicellular, and many are filamentous and have cell walls. The kingdom Fungi includes
phyla Chytridiomycota (the chytrids), Zygomycota (the conjugated fungi), Ascomycota (the sac
fungi), Basidiomycota (the club fungi), Deuteromycota (the imperfect fungi), and Glomeromycota.
This classification was established according to their mode of sexual reproduction or using molecular
data [35]. Fungi were efficiently used to treat water samples contaminated with micropollutants [36,37],
pharmaceuticals in particular (Table 1). They are long recognized for their abilities to transform
a broad range of recalcitrant compounds using nonspecific intracellular and extracellular oxidative
enzymes [38–40]. The physiology and colonization strategy of mycelial fungi allows them to more
easily withstand sudden changes in pH or humidity, as well as to degrade more efficiently complex
organic compounds [41], although they are limited by a long growth cycle and spore formation [42].
2.1.1. Treatment Systems
Fungal reactors, also termed mycoreactors, can be suspended growth (such as slurry reactors) or
immobilized systems (such as trickling filters, rotating biological contactors, upflow fixed-film reactors,
and fluidized-bed reactors); these latter allow a fast biodegradation. Mycoreactors can be operated in
batch, semi-batch, sequencing batch, or continuous mode, like other biological reactors. They can also
be operated under aerobic or anaerobic conditions. Mycoreactors for submerged growth include stirred
tanks, packed bed, bubble column, and air-lift [43], with stirred tanks as the most common, where the
culture medium is agitated mechanically, providing a good fluid mixture and a good oxygenation.
However, they have disadvantages such as the stress generated by the agitation, their impracticality
for certain microorganisms, and the high energy consumption for high agitation speeds. Air-lifts are
pneumatically agitated mycoreactors very similar to the stirred tanks; however, the fluid mixing is
done by injecting air or compressed gas into the base of the bioreactor. This bioreactor is usually
cylindrical so that the air bubbles remain as long as possible in the fluid. Compared with stirred tank,
air-lifts have worse mixing rates; however, they generate less stress to the microorganisms [44,45].
Pellet-forming fungi, which are easier to recover at the end of the treatment, are cultivated in aerated
fluidized-bed or suspended air-lift loop reactors [43].
2.1.2. Mechanisms of Removal
White-rot fungi (WRF), in particular, belong to the Basidiomycota phylum, whose potential was
explored in several studies about the removal of pharmaceuticals (Table 1) [46–72]. These strains
are filamentous wood-degrading fungi, ubiquitous in nature, able to mineralize lignin efficiently.
The name white rot derives from the bleached appearance of the wood attacked by these fungi
due to the removal of the dark-colored lignin. The same mechanism that gives these fungi the
potential to degrade lignin also allows them to degrade a wide variety of recalcitrant pollutants,
such as pharmaceuticals, making them promising and attractive microorganisms for wastewater
bioremediation. They are able to mineralize a wide variety of pollutants since their enzymatic system
is non-specific, non-stereoselective, and based on free-radical levels [73]. Pollutant degradation
(Figure 3) seems to involve either an intracellular enzymatic system (i.e., cytochrome P450 system)
or an extracellular enzymatic system (mainly lignin peroxidase, manganese peroxidase, laccase,
and versatile peroxidase) [73,74]. Peroxidases are secreted during secondary metabolism of WRF in
the presence of nitrogen, carbon, or sulfur limitations, while laccases are glycosylated multicopper
oxidoreductases that are produced during primary metabolism [75]. Peroxidases generally show higher
redox potential than laccases; however, peroxidases suffer deactivation in the presence of hydrogen
peroxide while laccases do not [76–78]; laccase performance seems to be affected by the presence of
chlorine ions forms [79]. Lignin peroxidase catalyzes the one-electron oxidation of various aromatic
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compounds, with subsequent formation of aryl cation radicals which are decomposed spontaneously
by various pathways. Manganese peroxidase catalyzes the oxidation of Mn2+ to Mn3+, which in turn
can cause oxidation of several phenolic substrates [80]. Fungal laccases were reported in several studies
since these enzymes have wide substrate ranges and use only oxygen as the final electron receptor,
producing water as the only by-product [65,81–103]. In many cases, preference was given to the use of
isolated enzymes (enzymatic bioremediation) instead of the use of fungi biomass in order to reduce
the time of treatment, to avoid the lag phase of fungal growth, to reduce sludge production, and to
facilitate process control [39]. It was found that Phanerochaete chrysosporium, a major WRF, does not
have laccase genes [104]. Trametes versicolor is a WRF frequently cited in the literature that was shown
to be effective in the removal of different pharmaceuticals (Table 1) [46,47,50–55,57–62,72].
For example, strains of Trametes versicolor, Irpex lacteus, Ganoderma lucidum, and Phanerochaete
chrysosporium were simultaneously tested in the removal of ibuprofen, clofibric acid, and carbamazepine.
The results suggested that clofibric acid and carbamazepine degradation occurred intracellularly by the
cytochrome P450 system of Trametes versicolor [46]. Using the same fungus, Nguyen et al. [54] compared
the removal of trace organic contaminants (including pharmaceuticals and steroid hormones) by
alive, intracellular enzyme-inhibited and chemically inactivated whole-cell preparations, and a fungal
extracellular enzyme extract, predominantly laccase. The low degradation of some hydrophobic
compounds by the extracellular extract, and the impact of intracellular cytochrome P450 system
inhibition on the degradation of some trace organic contaminants by the whole-cell culture indicated the
importance of extracellular enzyme-independent catalytic pathways. Rodriguez-Rodriguez et al. [49]
studied the removal of sulfonamides sulfapyridine and sulfathiazole by Trametes versicolor. Complete
degradation was achieved for both compounds, although a longer period of time was needed to
completely remove sulfathiazole when compared to sulfapyridine. In order to determine the effect of
cytochrome P450 inhibitors, piperonyl butoxide or 1-aminobenzotriazole was added in the experiments
performed. The results showed that sulfathiazole degradation was partially suppressed, while no
additional effect was observed for sulfapyridine. In another study, Trametes versicolor was able to degrade
carbamazepine in aqueous medium in an air-pulsed fluidized bioreactor in batch and continuous
mode. In batch mode, carbamazepine concentration decreased 96%, while, in continuous mode,
carbamazepine concentration decreased 54%. In this case, it was not possible to establish a correlation
between extracellular laccase activity and carbamazepine degradation, since laccase and manganese
peroxidase levels were negligible during the initial period, which may indicate that these enzymes
were involved in an early stage of carbamazepine removal [47].
Rodarte-Moralez et al. [48] studied the removal of six pharmaceuticals (citalopram, sulfamethoxazole,
diclofenac, ibuprofen, naproxen, and carbamazepine) from an initial mixture by three other WRF
strains, Bjerkandera sp. R1, Bjerkandera adusta, and Phanerochaete chrysosporium, and also confirmed
their enzymatic activity, particularly manganese peroxidase. An intense enzymatic activity was also
detected during the individual degradation of 17α-ethinylestradiol and carbamazepine by ligninolytic
fungi strains Pleurotus sp. P1, Pleurotus ostreatus BS, and a (unidentified) basidiomycete strain BNI.
During 17α-ethinylestradiol degradation by Pleurotus sp. P1, laccase and manganese peroxidase
activity was detected, while, during carbamazepine degradation by strain BNI, laccase, manganese
peroxidase, and lignin peroxidase activity was detected [68].
Nguyen et al. [51,54] revealed in their studies that the enzymatic performance of laccase,
in particular, can be enhanced by the addition of mediators. These authors studied the effect of
continuous dosing of a mediator (1-hydroxybenzotriazole) in the removal of trace organic contaminants,
including pharmaceuticals, from an initial complex mixture by Trametes versicolor. Becker et al. [63]
studied the removal of 38 antibiotics (majority non-phenolic) from a mixture using immobilized laccase
(Trametes versicolor), in an enzymatic membrane reactor, with or without the addition of syringaldehyde
as a mediator. Thirty-two out of 38 antibiotics were removed by up to 50% when a mediator was
used. In contrast, no significant removal was observed in experiments applied without a mediator.
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Indeed, mediators can be oxidized by laccase to free radicals, which in turn can oxidize pollutants less
specifically, increasing the variety of pollutants potentially degraded by these enzymes [105].
Synthetic and natural laccase mediators were used in enzymatic studies. Synthetic mediators
include 2,2′-azino-bis(3-ethylbenzothiazoline-6sulfonate) and 1-hydroxybenzotriazole, while natural
phenolic mediators include syringaldehyde and acetosyringone. Natural mediators are more
economically feasible and more environmentally friendly than artificial mediators [106]. Each mediator
has a specific catalytic mechanism [107,108]. The effect of a mediator depends on the radicals formed,
the mediator recyclability, and the laccase stability in the mediator’s presence [106,107,109,110]. Despite
the proven increase in efficiency, mediators incur additional costs, and can cause toxicity [63,111] and
laccase inactivation [112–114]. For example, Becker et al. [63] observed that, although the addition of
syringaldehyde enhanced the removal of antibiotics, unspecific toxicity was also induced.
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2.1 3 Factors That Influence the Degradation Capability
Fungi are able to degrade very l l concentrations levels [73] and withstand
a i range of pH, further enhancing t eir de radation capabili y [115]. Nevertheless, mycoremediaton
requires sp cific and controlled onditions in order to maintain a durable and efficie t process. Fu gi
oxidative metabolism can be s rongly ffected by th presence o nutrients, pH, immobilization on
different supports, and agitatio /static g owth conditions [31]. Zhang and Geißen [116] tested the
degradation of carbamazepine nd diclofen c by lig in peroxidase produced by WRF Phanerochaete
chrysosporium in various conditions. It was found that lignin peroxidase completely degraded diclofenac
at pH 3.0–4.5 and 3–24 mg·L−1 H2O2, while the degradation efficiency of carbamazepine was mostly
below 10%. The addition of veratryl alcohol and the high temperature (30 ◦C) did not enhance
the carbamazepine degradation. In another study, the removal of carbamazepine by Phanerochaete
chrysosporium in a plate bioreactor operated in batch and continuous systems showed that carbamazepine
removal depends on a sufficient nutrient supply. Carbamazepine concentration decreased about 80%
when a diluted synthetic nutrient medium was fed to the reactor and decreased about 60% when a real
effluent with additional glucose and nitrogen was fed to the reactor, after 100 days of incubation [49].
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By opposition, 17α-ethinylestradiol was completely degraded by Pleurotus sp. P1, Pleurotus ostreatus BS,
and a (unidentified) basidiomycete strain BNI, in the presence or absence of another carbon source [68].
Becker et al. [57] showed that the degradation of hormones by laccases is feasible even at very
low enzyme concentrations, and that immobilized enzymes displayed better removal performance
compared to the free enzyme. Indeed, enzyme immobilization provides a more suitable environment
for enzymes and may result in an increasing enzyme stability concerning pH, temperature, and storage
time. Efficient use of immobilized cells requires, however, control of physiological/metabolic changes
occurring either during the immobilization process or during the biotransformation phase. Enzyme
immobilization can be done with irreversible methods (e.g., covalent binding and entrapment) or
reversible methods (e.g., adsorption, ionic binding, affinity binding, chelation, and disulfide bonds).
The selection of the immobilization method is based on technical–economic criteria. Since cost is
a preponderant parameter, the simplest ones are usually used [117].
An eventual contamination with bacteria can negatively affect the efficiency since it can generate
competition for the substrate, damage fungi mycelium, disrupt biomass growth, and destabilize
fungal activity [118,119]. To avoid bacterial contamination, some strategies can be implemented. In the
biological treatment system, the pH has great influence, since it acts in the development and selection of
the microorganisms. Therefore, it is convenient to operate under acidic conditions, since the optimum
pH for fungi growth is lower than the optimum pH for most bacteria. Other possible strategies include
pretreatment by coagulation–flocculation of wastewater, since a reduction of the initial bacterial count
usually occurs; coupling the bioreactor with a micro-screen, which allows the retention of fungal
biomass and, simultaneously, the washout of bacteria with effluent; the use of disinfectant agents that
allow the selection and/or inactivation of bacteria; the immobilization of fungal strains in different
carriers; and the periodic replacement of fungal biomass [118].
Sterility conditions do not appear to be a mandatory requirement to apply Trametes versicolor in
pharmaceutical removal. The studies performed showed that this microorganism was able to partially
or completely remove pharmaceuticals either under sterile or non-sterile conditions [50,52].
2.1.4. Concluding Remarks and Future Challenges for Mycoremediation
In general, studies indicate a significant reduction in wastewater toxicity after treatment.
Some fungi strains found in the literature [46,47,50,52,53,61,120] proved to be effective in pharmaceutical
removal (Table 1). Final products were reported to be less toxic or more biodegradable than the parent
compounds, which emphasizes the potential of fungi as remedial agents.
Genetic tools can represent an essential step to improve fungi performance and overcome some
limitations associated with the process. The sequencing of fungi genomes will allow the development
of new genetic techniques to improve metabolic and adaptive processes, and consequently achieve
efficient bioremediation [121]. To date, efforts met limited success, and there is still a long way to go
before the introduction of modified fungi in remediation processes. The first complete eukaryotic
genome belongs to the yeast Saccharomyces cerevisiae [122]. Several projects released information
about the genome sequences of fungi Aspergillus nidulans, Aspergillus fumigatus, Neurospora crassa,
and Coprinus cinereus [123]. The thirty-million-base-pair genome of WRF Phanerochaete chrysosporium
strain RP78 was sequenced using a whole-genome shotgun approach [124]. The genome revealed
genes encoding oxidases, peroxidases, and hydrolytic enzymes involved in wood decay, which opens
new horizons related to the process of biodegradation of organic pollutants and pharmaceuticals in
particular [125]. However, the risks involved in the use of genetically modified fungi, their impact on
the environment and human health, and existing legal limitations must be considered [126].
2.2. Phycoremediation
Algae (“phyco” from Greek) include prokaryotic organisms (cyanobacteria) and eukaryotic
organisms (all the algae species) that contain chlorophyll and carry out oxygenic photosynthesis.
Although most algae are of microscopic size and, hence, are clearly microorganisms (microalgae),
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several forms are macroscopic (macroalgae) grow to over 30 m in length. Algae are either unicellular
or colonial. When the cells are arranged end to end, the alga is said to be in filamentous form [127].
According to Ruggiero et al. [128], algae can be classified according to the pigments they possess. Algae
color differences arise due to the proportions of different auxiliary photosynthetic pigments present in
addition to the green chlorophylls. Chlorophyta (the green algae) and Euglenophyta (the euglenoids)
are green since chlorophyll a is dominant. If carotenoids are dominant in the algae, they give them
a golden-brown color, such as Chrysophyta, whose chloroplasts contain chlorophylls a, c1, and c2,
fucoxanthin, and β-carotene, which are the carotenoids responsible for the golden-brown color.
Dinophyta (the dinoflagellates), have a reddish, greenish, or brown appearance due to chlorophylls
a and c2 and carotenoids. Rhodophyta (the red algae) have chlorophylls a and d, phycobiliproteins,
and floridean starch as storage products accumulated in the cytoplasm outside the chloroplast.
In Phaeophyta (the brown algae), color results from the dominance of fucoxanthin over chlorophylls a,
c1, and c2.
Algae are highly adaptive microorganisms and can grow autotrophically, heterotrophically,
or mixotrophically. They can grow in very harsh environmental conditions, such as low nutrient
levels, and extreme pH and temperature, which is an advantage over some species of fungi [129].
Unlike strictly heterotrophic microorganisms, the decrease in nutrient concentration does not limit
the growth of algae [130]. Microalgae can acclimatize to changes in temperature, salinity, light,
and nutrient availability, which allows the improvement of their tolerance and biodegradation
capacity. This adaptation mechanism to extreme conditions is explained by genetic changes caused
by spontaneous mutation or physiological adaptation [131,132]. Xiong et al. [133] evaluated the
biodegradation capability of Chlorella vulgaris after acclimation with multiple exposures to levofloxacin
and an increase in salinity. Results showed that levofloxacin biodegradation was significantly improved
after acclimation.
The characteristics of domestic wastewaters is usually suitable for the cultivation of microalgae,
since wastewaters represent a source of nutrients. From an environmental perspective, photosynthetic
microalgae are fascinating since they can sequester atmospheric carbon dioxide for their own growth,
contributing to the mitigation of this pollutant. In a properly controlled process, the association of
microalgae with bacteria may result in a very synergistic relationship; microalgae provide oxygen
while bacteria release carbon dioxide, which allows a significant reduction of oxygen needs in the
treatment process [134–137]. In addition, microalgae treatment supplies an environment that increases
the mortality of pathogenic organisms due to the pH elevation [138]. A win–win situation of using
microalgae in wastewater bioremediation offers a tertiary biotreatment of wastewater coupled with the
production of potentially valuable biomass as a bioresource for biofuel or high-value by-products [139].
2.2.1. Treatment Systems
From the economic point of view, open systems are preferred for wastewater phycoremediation.
Operational factors that influence algae growth are essentially mixing, dilution rate, and depth [140].
Open ponds are the most usual for microalgae cultivation since they require lower investment costs
and operational capital. Commercially, algae cultivation is mainly performed on open channels stirred
with a paddlewheel (raceway), since they are less expensive and easier to construct and operate.
There is, however, a high risk of contamination and low productivity due to a poor mixing regime
and light penetration, and also due to the difficulty of controlling the operating conditions [141].
Facultative, maturation, and high-rate algal ponds are the most used open systems for wastewater
treatment, with the first two being the most used. The major differences between them are the depth
and origin of the influent. The major constraints include poor light utilization by the cells, water loss
due to evaporation, diffusion of carbon dioxide to the atmosphere, temperature fluctuations, inefficient
stirring, and large space requirements for microorganism growth [142]. Open systems usually operate
under long hydraulic retention time (between eight and 14 days) in order to consume carbon dioxide
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during the day (photosynthesis) and provide oxygen for aerobic biodegradation. Sunlight intensity
influences photosynthetic activity, leading to pH and dissolved oxygen variations [143–145].
Closed systems were designed to overcome the problems associated with open systems.
Unlike open systems, closed systems allow greater control of the process; however, they are expensive
to install and to maintain [146]. Closed systems are most suitable for pure algae strains, and their
design must be carefully optimized for each individual strain according to its unique physiological
and growth characteristics. These systems avoid losses by evaporation, and reduce the contamination
risk and the losses of carbon dioxide to the atmosphere [147]. Closed systems, which are mostly
photobioreactors, exist in various design configurations (e.g., horizontal or serpentine tube, flat-plate,
bubble column, air-lift column, and stirred tank). Flat-plate photobioreactors have space constraints,
and tubular photobioreactors have design limitations. Column photobioreactors are the most efficient,
which provide efficient mixing, the highest volumetric mass transfer rates, and the best controllable
growth conditions. Some difficulties arise with scale-up caused by inhomogeneous distribution of
light inside the culture. The productivity is negatively affected by central, light-deprived zones [148];
therefore, to facilitate penetration of light, photobioreactors are made of glass, transparent plastic
material, or sturdy polythene.
Among all the drawbacks associated with phycoremediation, harvesting is one of the most
challenging processes integrated in the removal treatment. The harvesting process may account
for 30% of total microalgae biomass production cost. Several factors affect the harvesting, such as
microalgae strain and operational parameters (hydraulic and solid retention times) [149]. Harvesting
technologies may involve one or more steps, and different physical (e.g., centrifugation, gravity
sedimentation, filtration, and dissolved air flotation), chemical (e.g., chemoflocculation), and biological
(e.g., bioflocculation and microalgae immobilization) processes.
Most of these processes are limited by high costs, long processing times, high energy consumption,
and low recovery [150,151]. The choice of the harvesting method depends on the microalgae characteristics,
such as the density and size of algal cells, as well as the product derived from the algal biomass [152].
The most environmentally friendly method is bioflocculation as it involves formation of
extracellular biopolymers that help natural flocculation of small particles [150,151]. Some microalgae
species flocculate more readily than others, and these microalgae can be mixed with other species
to induce flocculation [153,154]. However, this method may be not efficient due to the small size of
microalgae cells and their fast growth. Further research is required to understand the underlying
mechanism associated with this process.
New technologies were considered, namely, the addition of other microorganisms, such as bacteria
and some fungal species, to the microalgae culture [135]. In the first case, microalgae and bacteria may
form flocs that settle more easily than single microalgae. It is necessary to add an extra organic substrate
to allow bacteria growth [135], which can be provided by using wastewater. The presence of an organic
carbon source in wastewater allows both organisms to thrive together [155,156]. The main disadvantages
are the influence of dominant microalgae species and the variability of wastewaters [135]. In the second
case, some filamentous fungi can pelletize, entrapping the microalgae cells, which facilitates the harvest
by simple sieve filtration or sedimentation in most cases [157]. It is not necessary to add an extra sugar
to allow fungi growth [158]. Co-pelletization efficiency seems to depend both on fungi and microalgae
strains and on culture conditions (in particular on the pH value). The choice of fungi strains will be the
key issue since it determines the overall pelletization efficiency and, therefore, can have a direct impact
on the subsequent processes. Since this method does not require the addition of chemicals or inputs of
energy, it may offer a solution to two of the major problems of harvesting processes, the high cost and
high energy consumption [159]. The competition of nutrients between fungi and microalgae is believed
to occur mostly in heterotrophic conditions, since microalgae need external carbon sources to support
their growth, or in autotrophic conditions, when other nutrients, such as organic nitrogen, are limited.
In this context, neither fungi nor microalgae cells will reach their maximum growth compared with
their growth in individual pure cultures [160]. It is not clear if co-culturing fungi affects the growth
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and nutrient assimilation of microalgae [161]. It is also unclear how the use of fungi for pelletization is
fundamentally different or superior to the use of bacteria for bioflocculation [161,162].
2.2.2. Mechanisms of Removal
Studies about the removal of emerging contaminants (such as pharmaceuticals) with algae are limited;
therefore, the mechanisms involved are not yet very clear (Table 1) [163]. The possible mechanisms
involved in algal–bacterial systems (Figure 3) seems to be biodegradation, biomineralization
(bioprecipitation), biosorption (cell adsorption and/or bioaccumulation), stripping (volatilization),
and photodegradation, due to the effect of light [163–165]. However, volatilization can be
considered negligible for most pharmaceuticals, because of their low Henry’s constant values [166].
The bioaccumulation of pharmaceuticals in algae cells can induce the generation of reactive oxygen
species, free radicals (e.g., O2•—superoxide radicals, OH•—hydroxyl radical, HO2•—perhydroxy
radical, and RO•—alkoxy radicals) and nonradical forms (e.g., H2O2—hydrogen peroxide and
1O2—singlet oxygen). At normal levels, these species act as essential signaling molecules to control
cellular metabolism; however, at excess levels, these species can cause severe damage to cellular
components and an increased rate of mutagenesis that ultimately leads to programmed cell death [167].
Such as for fungi, pollutant degradation by algae seems to involve intracellular and extracellular
enzymatic systems (Figure 3). Intracellular degradation of pharmaceuticals involves a phase I enzyme
(cytochrome P450) [163,168–173] and a phase II enzyme (e.g., glutathione-S-transferases) [171].
Extracellular degradation of pharmaceuticals involves the excretion of various extracellular polymeric
substances, such as polysaccharides, protein, enzymes, substituents (polysaccharide-link methyl and
acetyl groups), and lipids to their surrounding environment. These extracellular polymeric substances
can form a hydrated biofilm matrix that acts as an external digestive system since they keep extracellular
enzymes close to the cells [174].
Peng et al. [168] studied the removal of progesterone and norgestrel by the microalgae Scenedesmus
obliquus and Chlorella pyrenoidosa. According to the authors, biotransformation was found to be the
main mechanism for the removal of progestogens. Hydroxylation, oxidation/reduction, and side-chain
breakdown were proposed to be involved in the algal transformation of the target compounds by
Chlorella pyrenoidosa. Xiong et al. [169] studied the removal of carbamazepine by the microalgae
Chlamydomonas mexicana and Scenedesmus obliquus. The results showed that both species simultaneously
promoted biodegradation, adsorption, and bioaccumulation of carbamazepine. De Godos et al. [164]
studied the mechanisms of tetracycline removal from a synthetic wastewater by Chlorella vulgaris and
identified photodegradation and biosorption as the most important.
2.2.3. Factors That Influence the Degradation Capability
There are several factors that affect the degradation of pharmaceuticals, which are mainly related to
the operation conditions, reactor configuration, and the species present. Matamoros et al. [175] studied
the removal of emerging organic compounds, including pharmaceuticals, from a real wastewater by
the marine algae Lessonia nigrescens Bory and Macrocystis integrifolia Bory in two pilot-scale high-rate
algal ponds. Removal efficiency ranged from negligible to up to 90% and was only affected by the
hydraulic retention time during the cold season. This effect was not observed in the warm season.
De Godos et al. [164] studied the removal of tetracycline by Chlorella vulgaris in two pilot-scale
high-rate algal ponds operated in batch mode. The study demonstrated that the shallow geometry of
high-rate algal ponds is advantageous to support tetracycline’s photodegradation.
Díaz-Garduño et al. [176] studied the removal of organic compounds, including pharmaceuticals,
from a real wastewater, by the microalga Coelastrum sp., in a pilot-scale photobioreactor and
a multibarrier treatment. The multibarrier treatment was the most effective treatment regarding
the removal efficiencies. The photobioreactor showed different removal percentages depending on the
initial effluent composition.
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Hom-Diaz et al. [177] observed that the removal of pharmaceuticals from domestic wastewater in
a pilot-scale tubular photobioreactor, in two seasonal periods (September–October; October–December),
was highly impacted by temperature and solar irradiation.
The removal of several pharmaceuticals present in wastewater by green algal species, in a real-scale
photobioreactor, was positively correlated with light intensity inside the culture, with stronger
correlation when the data collected during the night were excluded [178].
Lai et al. [179] studied the removal of natural steroid estrogens (estradiol, estrone, estriol,
and hydroxyestrone) and synthetic steroid estrogens (estradiol valerate, estradiol, and ethinylestradiol)
by the alga Chlorella vulgaris, using batch-shaking experiments in the light and in the dark. The results
showed that estradiol and estrone were interconvertible in the presence or absence of light. In the
presence of light, 50% of estradiol was further metabolized to an unknown product. Estradiol valerate
was hydrolyzed to estradiol and then to estrone. Estrone, hydroxyestrone, estriol and ethinylestradiol
were relatively stable, and did not suffer biotransformation. Recently, a combination of photobioreactor
and open-pond cultivation was suggested; the first allows a fast algae growth, while the second ensures
mass cultivation [141].
In many cases, the complete removal of a compound requires the interaction of several groups of
microorganisms (consortium), each of which is responsible for a degradation step. This interaction is
extremely positive because pure cultures, isolated from this consortium, may not be able to completely
remove this compound as the single carbon source, or the removal rate may be significantly lower
than that obtained with the mixed crop that gave rise to it. Shi et al. [180] studied the removal of
synthetic hormone 17α-ethinylestradiol and the natural hormones estrone and 17β-estradiol, from
a synthetic wastewater, by an alga (Anabaena cylindrica, Chlorococcus, Spirulina platensis, Chlorella,
Scenedesmus quadricauda, and Anaebena) and duckweed (Lemna) pond system. The results showed that
all hormones were effectively removed from the continuous-flow algae and duckweed pond even
when their concentrations were at ng·L−1 level. The simultaneous presence of algae and duckweed
accelerated the removal of hormones from the synthetic wastewater since hormones could be quickly
sorbed either on duckweed or algae and then degraded by both microorganisms [180].
Although several studies demonstrated the applicability of algae for micropollutant removal
from wastewater [137,181], limitations and knowledge gaps still exist to rely on algae biomass
production as an effective mean for micropollutant removal. For example, when Wang et al. [182]
exposed the freshwater alga Chlorella Pyrenoidosa to a triclosan concentration of 800 mg·L−1, a reductive
dechlorination product of triclosan was formed. Algal cell growth was affected by their toxicity. Algal
cell chloroplasts were damaged, decreasing the energy supply for algal growth, which produced
an adverse effect on the effectiveness of triclosan biodegradation. Furthermore, most of the studies
tested the algae’s ability to remove pollutants, which grew in unpolluted media before the treatment,
and ignored the toxic stress caused by the pollutant and its influence on the removal capability. It is
possible that the sensitivity or tolerance of algae changes after the first contact with the pollutant and,
therefore, it may influence the removal efficiency of subsequent batch treatments.
Chen et al. [183] investigated the removal efficiency of cefradine by Chlorella pyrenoidosa in
a sequencing batch reactor and identified different results between the first batch treatment and the
second, where higher algal growth inhibition rates were observed; however, the alga produced more
photosynthetic pigments, enhancing its photosynthetic metabolism as a way of adaptation to more
harmful environmental conditions.
2.2.4. Concluding Remarks and Future Challenges
Some algae strains found in the literature [64,133,148,164,166,168–170,176–180,182–194] proved
to be effective in pharmaceutical removal (Table 1).
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Table 1. Bioremediation studies with fungi and algae for removal of pharmaceuticals. WWTP—wastewater treatment plant.
Compounds Compounds Source Strains Removal Mechanisms Technologies Reference
Ibuprofen, clofibric acid, and carbamazepine Synthetic media
Fungi
Trametes versicolor
Irpex lacteus
Ganoderma lucidum
Phanerochaete chrysosporium
Biodegradation
Adsorption Laboratory-scale batch assays [46]
Carbamazepine Synthetic media FungiTrametes versicolor
Biodegradation
Adsorption
Laboratory-scale batch assays
Pilot-scale glass air-pulsed
fluidized bioreactor
(continuous and batch feed)
[47]
Citalopram, fluoxetine, sulfamethoxazole, diclofenac, ibuprofen,
naproxen, carbamazepine, and diazepam Synthetic media
Fungi
Bjerkandera sp. R1
Bjerkandera adusta
Phanerochaete chrysosporium
Biodegradation Laboratory-scale batch assays [48]
Carbamazepine Synthetic media FungiPhanerochaete chrysosporium
Biodegradation
Biosorption
Pilot-scale plate bioreactor
(continuous and batch feed) [49]
Naproxen, ibuprofen, acetaminophen, salicylic acid, ketoprofen, codeine,
erythromycin, metronidazole, ciprofloxacine, azithromycin, cefalexine,
propranolol, carbamazepine, 10,11-epoxycarbamazepine,
2-hydroxycarbamazepine, acridone, and citalopram
Urban wastewater FungiTrametes versicolor Biodegradation
Pilot-scale air-fluidized
bioreactor (batch feed) [50]
Carbamazepine, ibuprofen, clofibric acid, ketoprofen, metronidazole,
triclosan, 17-α-ethinylestradiol, 17-β-estradiol-17-acetate, estrone, estriol,
17-β-estradiol, gemfibrozil, amitriptyline, primidone, salicylic acid,
diclofenac, naproxen
Synthetic media FungiTrametes versicolor
Biodegradation
Biosorption
Laboratory-scale batch assays
Pilot-scale fungus-augmented
membrane bioreactor
(continuous feed)
[51]
Acetaminophen, ibuprofen, ketoprofen, naproxen, salicylic acid, codeine,
phenazone, dexamethasone, diclofenac, piroxicam Hospital wastewater
Fungi
Trametes versicolor Biodegradation
Pilot-scale glass air pulsed
fluidized bioreactor (batch feed) [52]
X-ray contrast agent iopromide and antibiotic ofloxacin Hospital wastewater FungiTrametes versicolor Biodegradation
Laboratory-scale batch assays
Pilot-scale glass air-pulsed
fluidized bioreactor (batch feed)
[53]
Metronidazole, salicylic acid, primidone, amitriptyline, carbamazepine,
ketoprofen, naproxen, ibuprofen, gemfibrozil, diclofenac, triclosan,
estriol, estrone, 17-α-ethinylestradiol, 17-β-estradiol,
17-β-estradiol-17-acetate
Synthetic media FungiTrametes versicolor
Biodegradation
Biosorption Laboratory-scale batch assays [54]
Cefalexin, ciprofloxacin, metronidazole, trimethoprim, tetracycline,
ketoprofen, acridone, carbamazepine, a carbamazepine metabolite,
ciprofloxacin, metronidazole and its hydroxilated metabolite, β-blocker
carazolol, diazepam, naproxen, cephalexin, tetracyclin, sertraline,
paroxetine, gemfibrozil, amlodipine, furosemide, dimetridazole,
azythromycin, ronidazole, olanzapine, piroxicam, β-blockers metoprolol
Veterinary hospital
wastewater
Fungi
Trametes versicolor Biodegradation
Pilot-scale glass air-pulsed
fluidized bioreactor
(continuous and batch feed)
[55]
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Table 1. Cont.
Compounds Compounds Source Strains Removal Mechanisms Technologies Reference
Acetaminophen, carbamazepine, diclofenac, metoprolol, naproxean,
ranitidine, and sulfamethoxazole Synthetic media
Fungi
Aspergillus niger
Algae
Chlorella vulgaris
Biodegradation Laboratory-scale batch assays [56]
Estrone, 17β-estradiol, 17α-ethinyl-estradiol, and estriol WWTP wastewater
Fungi
Trametes versicolor
Myceliophthora thermophila
Biodegradation
Adsorption Laboratory-scale batch assays [57]
17β-estradiol and 17α-ethinylestradiol Synthetic media FungiTrametes versicolor Biodegradation
Laboratory-scale batch assays
Pilot-scale glass air-fluidized
bioreactor (continuous feed)
[58]
Sulfapyridine, sulfapyridine, and sulfamethazine Synthetic media FungiTrametes versicolor
Biodegradation
Biosorption
Laboratory-scale batch assays
Pilot-scale air-pulsed
fluidized-bed bioreactor
(continuous feed)
[59]
Naproxen and carbamazepine Synthetic media FungiTrametes versicolor Biodegradation Laboratory-scale batch assays [60]
Sodium diclofenac Synthetic media FungiTrametes versicolor Biodegradation Laboratory-scale batch assays [61]
Ketoprofen Synthetic media FungiTrametes versicolor Biodegradation Laboratory-scale batch assays [62]
Diclofenac, ibuprofen, naproxen, carbamazepine, and diazepam Synthetic media FungiPhanerochaete chrysosporium
Biodegradation
Adsorption
Pilot-scale stirred tank reactor
and fixed-bed reactor
(continuous feed)
[64]
Tetracycline and oxytetracycline Synthetic media FungiPhanerochaete chrysosporium Biodegradation Laboratory-scale batch assays [65]
Phenolic compounds Pharmaceuticalindustry wastewater Pycnoporus sanguineus Biodegradation Laboratory-scale batch assays [66]
Diclofenac, ketoprofen and atenolol Hospital wastewater FungiPleurotus ostreatus
Biodegradation
Adsorption
Pilot-scale air-pulsed
fluidized-bed bioreactor
(continuous and batch feed)
Laboratory-scale batch assays
[67]
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Table 1. Cont.
Compounds Compounds Source Strains Removal Mechanisms Technologies Reference
17α-ethinylestradiol and carbamazepine Synthetic media
Fungi
Pleurotus sp. P1
Pleurotus ostreatus BS
(unidentified)
basidiomycete strain BNI
Biodegradation
Adsorption Laboratory-scale batch assays [68]
Acetaminophen Synthetic media FungiMucor hiemalis Bioconcentration Laboratory-scale batch assays [69]
Carbamazepine and clarithromycin Synthetic media
Fungi
Trichoderma
harzianumPleurotus ostreatus
Biodegradation Laboratory-scale batch assays [70]
Carbamazepine Synthetic media FungiPleurotus ostreatus Biodegradation Laboratory-scale batch assays [71]
Clofibric acid, gemfibrozil, ibuprofen, fenoprofen, ketoprofen, naproxen,
diclofenac, indomethacin, propyphenazone, and carbamazepine Synthetic media
Fungi
Trametes versicolor Biodegradation Laboratory-scale batch assays [72]
Levofloxacin Synthetic media AlgaeChlorella vulgaris
Biodegradation
Bioaccumulation Laboratory-scale batch assays [133]
Acetaminophen, ibuprofen, ketoprofen, naproxen, carbamazepine,
diclofenac, and triclosan WWTP wastewater
Algae
Lessonia nigrescens Bory
Macrocystis integrifolia Bory
Biodegradation
Photodegradation
Biosorption
Pilot-scale high-rate algal ponds [148]
Tetracycline Synthetic media AlgaeChlorella vulgaris
Photodegradation
Biosorption
Laboratory-scale batch assays
Pilot-scale high rate algal ponds
(batch feed)
[164]
Carbamazepine Synthetic media
Algae
Pseudokirchneriella
subcapitata
(and crustacean
Thamnocephalus and
cnidarian Hydra attenuata)
Bioaccumulation Laboratory-scale batch assays [166]
Progesterone and norgestrel Synthetic media
Algae
Scenedesmus obliquus
Chlorella pyrenoidosa
Biodegradation
Biosorption Laboratory-scale batch assays [168]
Carbamazepine Synthetic media
Algae
Chlamydomonas mexicana
Scenedesmus obliquus
Biodegradation
Adsorption
Bioaccumulation
Laboratory-scale batch assays [169]
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Table 1. Cont.
Compounds Compounds Source Strains Removal Mechanisms Technologies Reference
17α-Ethynylestradiol Synthetic media AlgaeDesmodesmus subspicatus
Biotransformation
Bioconcentration Laboratory-scale batch assays [170]
Analgesic and antiinflammatories, lipid regulators and antihypertensive,
psychiatric drugs and stimulant, antibiotics, and others WWTP wastewater
Algae
Coelastrum sp. Biodegradation
Pilot-scale photobiotreatment
microalgae and multi-barrier
treatment
[176]
Acetaminophen, ibuprofen, naproxen, salicylic acid, ketoprofen, codeine,
azithromycin, erythromycin, ciprofloxacin, ofloxacin, atenolol,
lorazepam, alprazolam, paroxetine, hydrochlorothiazide, furosemide,
and diltiazem
Domestic
wastewater
Algae
Undefined microalgae Biodegradation
Pilot-scale tubular
photobioreactor [177]
Alfuzosin, alprazolam, atenolol, atracurium, azelastine, biperiden,
bisoprolol, bupropion, carbamazepin, cilazapril, ciprofloxacin,
citalopram, clarithromycine, clemastine, clindamycine, clonazepam,
clotrimazol, codeine, cyproheptadine, desloratidin, dicycloverin,
diltiazem, diphenhydramin, eprosartan, fexofenadine, flecainide,
fluconazole, flupetixol, haloperidol, hydroxyzine, ibersartan, loperamide,
memantin, metoprolol, miconazole, mirtazapine, nefazodon,
orphenadrin, pizotifen, ranitidine, risperidone, roxithromycine,
sertraline, sotalol, sulfamethoxazol, terbutalin, tramadol,
trihexyphenidyl, trimetoprim, venlavafaxin, and verapamil
WWTP wastewater
Algae
Green algal species
(Tetradesmus dimorphus and
Dictyosphaerium, between
them)
Biodegradation Real-scale photobioreactor [178]
Estradiol, estrone, estriol and hydroxyestrone) and synthetic steroid
estrogens (estradiol valerate, estradiol, and ethinylestradiol Synthetic media
Algae
Chlorella vulgaris
Biotransformation
Bioconcentration Laboratory-scale batch assays [179]
17α-ethinylestradiol, estrone, and 17β-estradiol Synthetic media
Algae
Anabaena cylindrical
Chlorococcus
Spirulina platensis
Chlorella
Scenedesmus quadricauda
Anaebena
(and duckweed Lemna)
Biodegradation
Adsorption
Laboratory-scale batch assays
Pilot-scale plug flow reactor
(continuous feed)
[180]
Triclosan Synthetic media AlgaeChlorella Pyrenoidosa
Biodegradation
Biosorption Laboratory-scale batch assays [182]
Cefradinegree Synthetic media AlgaeChlorella pyrenoidosa Biodegradation
Pilot-scale batch-sequencing
reactor algae process (batch
feed)
[183]
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Table 1. Cont.
Compounds Compounds Source Strains Removal Mechanisms Technologies Reference
Ethinylestradiol Synthetic media
Algae
Ankistrodesmus braunii
Chlorella ellipsoidea
Chlorella pyrenoidosa
Chlorella vulgaris
Scenedesmus communis
Scenedesmus obliquus
Scenedesmus quadricauda
Scenedesmus vacuolatus
Selenastrum capricornutum
Biotransformation Laboratory-scale batch assays [184]
17α-boldenone, 17β-boldenone, 4-hydroxy-androst-4-ene-17-dione,
androsta-1,4-diene-3,17-dione, 4-androstene-3,17-dione, carbamazepine,
ciprofloxacin, clarithromycin, climbazole, clofibric acid, diclofenac,
enrofloxacin, erythromycin–H2O, estrone, fluconazole, gemfibrozil,
ibuprofen, lincomycin, lomefloxacin, norfloxacin, ofloxacin, paracetamol,
progesterone, roxithromycin, salicylic acid, salinomycin, sulfadiazine,
sulfadimethoxine, sulfameter, sulfamethazine, sulfamethoxzole,
sulfamonomethoxine, sulfapyridine, testosterone, triclosan,
trimethoprim, and tylosin
WWTP wastewater
Algae
Chlamydomonas reinhardtii
Scenedesmus obliquus
Chlorella pyrenoidosa
Chlorella vulgaris
Biodegradation Laboratory-scale batch assays [185]
Salicylic acid and paracetamol Synthetic media AlgaeChlorella sorokiniana Biodegradation
Pilot-scale reactor (batch and
semicontinuous feed) [186]
Paracetamol, salicylic acid, and diclofenac Synthetic media
Algae
Chlorella sorokiniana
Chlorella vulgaris
Scenedesmus obliquus
Biodegradation
Pilot-scale bubbling column
photobioreactor (batch and
semicontinuous feed)
[187]
Tributyltin Synthetic media
Algae
Chlorella miniata
C. sorokiniana
Scenedesmus dimorphus
S. platydiscus
Biodegradation
Adsorption
Absorption
Laboratory-scale batch assays [188]
Trimethoprim, sulfamethoxazole, and triclosan Synthetic media AlgaeNannochloris Sp.
Biodegradation
Adsorption Laboratory-scale batch assays [189]
Diclofenac, ibuprofen, paracetamol, metoprolol, carbamazepine and
trimethoprim, estrone, 17β-estradiol, and ethinylestradiol Synthetic media
Algae
Chlorella sorokiniana
Biodegradation
Photolysis
Biosorption
Laboratory-scale batch assays [190]
Water 2019, 11, 1555 17 of 36
Table 1. Cont.
Compounds Compounds Source Strains Removal Mechanisms Technologies Reference
Oxytetracycline, doxycycline, chlortetracycline, and tetracycline Synthetic media
Algae
Haematoloccus pluvialis
Chlorella sp.
Selenastrum capricornutum
Pseudokirchneriella
subcapitata
Biodegradation Laboratory-scale batch assays [191]
Salicylic acid or paracetamol Pharmaceuticalindustry wastewater
Algae
Chlorella sorokiniana Biodegradation
Pilot-scale bubbling column
photobioreactor (batch and
semicontinuous feed)
[193]
Ciprofloxacin Synthetic media AlgaeChlamydomonas mexicana Biodegradation Laboratory-scale batch assays [194]
β-estradiol and 17α-ethinylestradiol WWTP anaerobicsludge
Algae
Selenastrum capricornutum
Chlamydomonas reinhardtii
Biodegradation
Photodegradation
Adsorption
Laboratory-scale batch assays [195]
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Chen et al. [182] raised a question worthy for future researches related to the possible improvement
of the removal efficiency of pollutants by algae under optimal light conditions and after their acclimation.
The final step of the treatment, harvesting, which represents a significant amount of the production
cost and energy consumption, is one of the most challenging processes. One of the most environmentally
friendly methods is bioflocculation [150,151]; nevertheless, it may not be efficient enough due to the
small size of microalgae cells. Other technologies, namely, co-pelletization through the addition of
other microorganisms (bacterial and fungal species) to microalgae culture, which do not require the
addition of chemicals or inputs of energy, may be promising solutions. However, further research on
this topic is recommended.
Such as for mycoremediation, genetic tools can represent an essential step to improve algae
performance. However, genetically modified algae for bioremediation are rarely reported. An example
is a small laccase from Streptomyces coelicolor that was engineered by structure-based design and
site-directed mutagenesis to improve its activity on commercially relevant substrates. The variants
generated showed up to a 40-fold increased efficiency on 2,6-dimethoxyphenol, as well as the ability to
use mediators with considerably higher redox potentials [195].
3. Biosorption
Adsorption includes all the processes involving a physical or chemical interaction between the
surface of a solid material (adsorbent) and the pollutant (adsorbate); biosorption is a subcategory
of adsorption, and may be simply defined as the removal of substances from solution by biological
material (live or dead). It is a property of living and dead biomass to bind and abiotically concentrate
compounds [196,197]. In addition to being an efficient and low-cost process, biosorption offers
advantages over conventional processes, and avoids the use of chemicals, namely, nutrient supply [197].
3.1. Biosorption Materials
Activated carbon is the most widely and effectively used sorbent, since it has a porous structure
consisting of a network of interconnected macropores, mesopores, and micropores that provide a good
capacity for the adsorption of organic molecules due to its high specific surface area. However, it is
quite expensive, United States (US) $20−22/kg [198], and the higher the quality is, the greater the cost
is [199,200], which limits its widespread use. According to the Swedish Environmental Protection
Agency [201], the costs depend mainly on the size of the treatment plant. For facilities using granular
activated carbon, for 2000–10,000 population equivalent, the following costs are associated: 0.72 million
US $ for installation, 0.04 million US $/year of capital expenditure, 0.1 million US $/year of operating
expenditure, and less than 0.01 kWh/m3 of operational electricity consumption, corresponding to a total
cost of 0.09–0.11 US $/m3 of treated wastewater. It is verified that the annual operating expenditure
has a major contribution to the total cost and that the major fraction of the operating costs is due to
activated carbon, which demonstrates the need to look for low-cost adsorbents. This led to the search
for low-cost sorbents, which require little processing and that are abundant in nature [202]. In this
search, biosorbents from microorganisms were shown to be a promising alternative since, due to their
reduced size, they present high specific surface area and they were shown to be able to sorb different
organic and inorganic pollutants from solutions [203]. A wide range of microorganisms were studied
in biosorption processes; these include microalgae and fungi. The complexity of the microorganism
structure implies that there are many ways for the contaminants to be captured by the cells; in some
cases, these are still not very well understood. The cell wall is the first component that meets the
pollutants, where the solutes can be deposited on the surface or within the cell-wall structure.
Fungal cell walls are structurally complex with several functional groups such as carboxyl,
hydroxyl, amino, sulfonate, and phosphonate, which bring about the excellent adsorption properties
of fungi [204–208].
Algal cell walls exhibit some variations in their structure. The main groups present are amino,
amine, hydroxyl, imidazole, phosphate, and sulfate [209]. This availability of functional groups
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minimizes the selectivity problems and allows the high efficiency of removal to be more easily
achieved [210]. For example, Navarro et al. [211] proposed the formation of hydrogen bonds as the
main mechanism for the removal of sulfamethoxazole and sulfacetamide by marine algae Lessonia
nigrescens Bory and Macrocystis integrifolia Bory.
3.2. Treatment Systems
Biosorption can proceed in batch or continuous mode. Both modes are frequently employed to
conduct laboratory-scale experiments, while continuous mode is the most employed for industrial
applications. Packed-bed, fluidized-bed, and continuous-stirred-bed reactors are three types of design
used in biosorption experiments. Several studies showed that packed-bed columns are the most
suitable for liquid–solid separation, and scaling was found to be minimal [212,213]. Fluidized-bed and
continuous-stirred-bed reactors are only occasionally used, since fluidized-bed reactors require a high
flow rate, which is sometimes difficult to achieve, and stirred-bed reactors require that biomass be in
powdered form; beyond that, they have high associated costs and high requirements of operation and
maintenance [207,214].
In the last few decades, many patents were developed, focused on improving the sorption capacity
of biosorbents through their modification or immobilization, mainly for metal removal [197]. However,
further attention should be given to the removal of pharmaceuticals.
3.3. Mechanisms of Removal
Biosorption is a physico-chemical process that involves several mechanisms (e.g., adsorption,
ion exchange, surface complexation, and microprecipitation), as shown in Figure 4 [215]. Biosorbent
surfaces are characterized by active, energy-rich sites that are able to interact with compounds in
the adjacent aqueous phase due to their specific electronic and spatial properties. Sorption occurs
because, from the thermodynamic point of view, the molecules prefer to be in a low-energy state.
A molecule sorbed onto a surface has a lower energetic state on a surface than in the aqueous phase.
Therefore, the molecule is attracted to the surface and to a lower-energy state. The attraction of
a molecule to a surface can be caused by physical and/or chemical forces. Electrostatic forces govern the
interactions between most sorbates and biosorbents. These forces include dipole–dipole interactions or
London/van der Waals forces, and hydrogen bonds [216].
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Biosorption equilibrium is not established instantaneously. The mass transfer from the solution
to the sor ites within the adsorbent particles is constrained by m s t an fer resistances that
determine i e required to reach the state of equilibrium. The rate f adsorption is usually limited
by diffusion processes toward the external adsorbent surface and within the porous adsorbent particles.
The progress of the biosorption process includes four consecutive steps: transport of the sorbate
from the bulk liquid phase to the hydrodynamic boundary layer localized around the biosorbent
particle; transport through the boundary layer to the external surface of the biosorbent, termed film
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diffusion or external diffusion; pore diffusion and/or surface diffusion toward the interior of the
biosorbent particle (termed intraparticle diffusion or internal diffusion); and energetic interaction
between the sorbate molecules and the sorption sites.
Kinetic and equilibrium data are modeled using different approaches in order to explain the
biosorption mechanism of the pollutants’ removal [217]. The equilibrium distribution on the sorbed
pollutant between the biosorbent and the aqueous phase is required to determine the maximum
biosorbent’s uptake capacity. The sorption kinetics provides additional important information about
the sorption mechanism, especially the rate of pollutant removal. In wastewater treatment, kinetics
information is important for setting an optimum residence time of the wastewater at the biosolid
phase interface.
Typically, the dependence of the sorbed amount on the equilibrium concentration is determined
experimentally at constant temperature, and the measured data are subsequently described by
an appropriate isotherm equation.
For fixed-bed columns, the dynamic behavior and efficiency are described in terms of the
effluent/affluent concentration as a function of time (or volume of treated liquid), i.e., the breakthrough
curve. Experimental “breakthrough curve” determination allows verifying the applicability of a chosen
adsorption model for a given biosorbent/sorbate system and estimating the related mass transfer
coefficients [217].
3.4. Factors That Affect the Process
Several factors affect biosorption; most of them are common to adsorption processes, like pH,
temperature, contaminant concentration, nature of sorbent and sorbate, contact time, ionic strength,
the presence of other compounds, the use of dead or alive biomass [196,214,218], and the
presence/absence of metabolic processes, in the case of living cells [215]. In living organisms, metabolic
processes may affect physico-chemical biosorption mechanisms, pollutant bioavailability, chemical
speciation, and accumulation/transformation [196].
Organic pollutants have a wide diversity of chemical structures; therefore, factors such as the
molecular size, charge, solubility, hydrophobicity, and reactivity are important factors in biosorption.
Human pharmaceutical metabolites, for example, are usually more polar and hydrophilic than the
parent compounds; therefore, it is expected that they will not be significantly removed by sorption [219].
By changing the properties of the liquid phase (e.g., concentration, temperature, pH), sorbed
species may be released from the surface and transferred back into the liquid phase. This reverse
process is referred to as desorption.
In the study of Aksu and Tunc [220], the removal of penicillin G potassium salt by dried fungus
Rhizopus arrhizus was strongly dependent on the pH and temperature. Maximum sorption was observed
at initial pH values of 6.0 and at 35 ◦C. They also [220] explored the possibility of using the dried
fungus for the batch removal of penicillin G potassium salt from aqueous solution and compared
the experimental uptake with the results obtained with powdered activated carbon, in the same
conditions. The uptake capacity determined was 459.0 mg·g−1 and 375.0 mg·g−1 for dried Rhizopus
arrhizus and for an activated carbon (commercial powdered activated carbon, SIGMA, C-4386, washed
with hydrochloric acid), respectively.
The use of dead biomass has advantages compared to the use of live biomass, such as the absence
of toxicity limitations and the absence of nutrient requirement for microorganism’s growth; however,
live biomass has the advantage of using metabolic processes that complement the overall removal
process [220].
Tam et al. [188] investigated tributyltin removal from artificial wastewater by dead and live cells of
four microalgal species, Chlorella miniata, Chlorella sorokiniana, Scenedesmus dimorphus, and Scenedesmus
platydiscus. In general, dead cells were more efficient than live cells during the three days of exposure;
however, at the end of 14 days, removal efficiencies were identical to those that were reached
by live cells. More than 90% and 85% of tributyltin was removed by dead cells of Scenedesmus
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and Chlorella, respectively, in the first three days. After three days of treatment, total amount
of sorbed tributyltin per unit of biomass for dead cells of Chlorella miniata, Chlorella sorokiniana,
Scenedesmus dimorphus, and Scenedesmus platydiscus was, respectively, 11.3 ± 0.6, 4.0 ± 0.3, 1.31 ± 0.09,
and 0.35 ± 0.04 mg·g−1, while, for live cells, it was, respectively, 0.24 ± 0.03, 0.58 ± 0.12, 0.083 ± 0.003,
and 0.0603 ± 0.0005 mg·g−1. Many other studies allowed observing that the fast concentration decrease
in the beginning of the assays was caused by the sorption process, followed by a much slower
concentration decrease caused by other biological removal mechanisms. This fact is probably due to the
large surface area of the individual cells, which provides a large interface between the aqueous and cell
phases. Nevertheless, unlike the other removal mechanisms, sorption is an equilibrium process that ends
when equilibrium is reached, which may lead to an incomplete removal of pollutants [164,180,182,189].
Combining biosorption with other removal mechanisms seems to be a successful strategy for the
removal of pharmaceuticals.
3.5. Biosorption Potential as a Wastewater Treatment Technology
The potential of biosorption as a wastewater treatment technology was frequently cited in the
literature, as shown in Table 2. Usually, the performance of commercial adsorbents is very good due
to the high specific surface area and the high porosity, but they present high costs which prevents
their wide use, especially when high flowrates are involved. The use of biosorbents, which are
usually easily available, presents advantages such as their low cost, and a more eco-friendly and
sustainable nature. Like bioremediation, several aspects make biosorption a promising choice, since it
is a low-cost treatment, has low operating costs, does not produce chemical sludge to handle, and is
highly efficient [221]. Some disadvantages associated with the process are the low specificity and low
robustness of the systems [222], the impossibility of long-term use of the suspended biomass, and the
difficult separation of the biomass and the treated effluent [223]. The use of packed-bed columns
is considered the most suitable biosorption, allowing an easy liquid–solid separation. The use of
biosorbents in granulated form instead of powdered form presents the advantage of avoiding column
clogging. Furthermore, the immobilization of fungi and algae can increase the efficiency of the process
as it allows their use for several cycles [224].
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Table 2. Biosorption studies with fungi and algae for removal of pharmaceuticals.
Compounds Compounds Source Strains Removal Mechanisms Technologies Reference
Ibuprofen, clofibric acid, and carbamazepine Synthetic media
Fungi
Trametes versicolor
Irpex lacteus
Ganoderma lucidum
Phanerochaete chrysosporium
Biodegradation
Adsorption Laboratory-scale batch assays [46]
Carbamazepine Synthetic media FungiTrametes versicolor
Biodegradation
Adsorption
Laboratory-scale batch assays
Pilot-scale glass air-pulsed
fluidized bioreactor
(continuous and batch feed)
[47]
Carbamazepine Synthetic media FungiPhanerochaete chrysosporium
Biodegradation
Biosorption
Pilot-scale plate bioreactor
(continuous and batch feed) [49]
Carbamazepine, ibuprofen, clofibric acid, ketoprofen, metronidazole,
triclosan, 17-α-ethinylestradiol, 17-β-estradiol-17-acetate, estrone,
estriol, 17-β-estradiol, gemfibrozil, amitriptyline, primidone, salicylic
acid, diclofenac, naproxen
Synthetic media FungiTrametes versicolor
Biodegradation
Biosorption
Laboratory-scale batch assays
Pilot-scale fungus-augmented
membrane bioreactor
(continuous feed)
[51]
Metronidazole, salicylic acid, primidone, amitriptyline,
carbamazepine, ketoprofen, naproxen, ibuprofen, gemfibrozil,
diclofenac, triclosan, estriol, estrone, 17-α-ethinylestradiol,
17-β-estradiol, 17-β-estradiol-17-acetate
Synthetic media FungiTrametes versicolor
Biodegradation
Biosorption Laboratory-scale batch assays [54]
Estrone, 17β-estradiol, 17α-ethinylestradiol, and estriol WWTP wastewater
Fungi
Trametes versicolor
Myceliophthora thermophila
Biodegradation
Adsorption Laboratory-scale batch assays [57]
Sulfapyridine, sulfapyridine, and sulfamethazine Synthetic media FungiTrametes versicolor
Biodegradation and
biosorption
Laboratory-scale batch assays
Pilot-scale air-pulsed
fluidized bed bioreactor
(continuous feed)
[59]
Diclofenac, ibuprofen, naproxen, carbamazepine, and diazepam Synthetic media FungiPhanerochaete chrysosporium
Biodegradation
Biosorption
Pilot-scale continuous stirred
tank reactor and fixed-bed
reactor
[64]
Diclofenac, ketoprofen, and atenolol Hospital wastewater FungiPleurotus ostreatus
Biodegradation
Adsorption
Pilot-scale air-pulsed
fluidized-bed bioreactor
(continuous and batch feed)
Laboratory-scale batch assays
[67]
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Table 2. Cont.
Compounds Compounds Source Strains Removal Mechanisms Technologies Reference
17α-ethinylestradiol and carbamazepine Synthetic media
Fungi
Pleurotus sp. P1
Pleurotus ostreatus BS
(unidentified) basidiomycete
strain BNI
Biodegradation
Adsorption Laboratory-scale batch assays [68]
Tetracycline Synthetic media AlgaeChlorella vulgaris
Photodegradation
Biosorption
Laboratory-scale batch assays
Pilot-scale high-rate algal
ponds (batch feed)
[164]
Progesterone and norgestrel Synthetic media
Algae
Scenedesmus obliquus
Chlorella pyrenoidosa
Biodegradation
Biosorption Laboratory-scale batch assays [168]
Carbamazepine Synthetic media
Algae
Chlamydomonas Mexicana
Scenedesmus obliquus
Biodegradation
Adsorption
Bioaccumulation
Laboratory-scale batch assays [169]
Acetaminophen, ibuprofen, ketoprofen, naproxen, carbamazepine,
diclofenac, and triclosan WWTP wastewater
Algae
Lessonia nigrescens Bory
Macrocystis integrifolia Bory
Biodegradation
Photodegradation
Biosorption
Pilot-scale high-rate algal
ponds [175]
17α-ethinylestradiol, estrone, and 17β-estradiol Synthetic media
Algae
Anabaena cylindrical
Chlorococcus
Spirulina platensis, Chlorella
Scenedesmus quadricauda
Anaebena
(and duckweed Lemna)
Biodegradation
Adsorption
Laboratory-scale batch assays
Pilot-scale plug flow reactor
(continuous feed)
[180]
Triclosan Synthetic media AlgaeChlorella Pyrenoidosa
Biodegradation
Biosorption Laboratory-scale batch assays [182]
Tributyltin Synthetic media
Algae
Chlorella miniata
Chlorella sorokiniana
Scenedesmus dimorphus
Scenedesmus platydiscus
Biodegradation
Adsorption
Absorption
Laboratory-scale batch assays [188]
Trimethoprim, sulfamethoxazole, and triclosan Synthetic media AlgaeNannochloris Sp.
Biodegradation
Adsorption Laboratory-scale batch assays [189]
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Table 2. Cont.
Compounds Compounds Source Strains Removal Mechanisms Technologies Reference
Diclofenac, ibuprofen, paracetamol, metoprolol, carbamazepine and
trimethoprim, estrone, 17β-estradiol, and ethinylestradiol Synthetic media
Algae
Chlorella sorokiniana
Biodegradation
Photolysis
Biosorption
Laboratory-scale batch assays [190]
β-estradiol and 17α-ethynylestradiol WWTP anaerobicsludge
Algae
Selenastrum capricornutum
Chlamydomonas reinhardtii
Biodegradation
Photodegradation
Adsorption
Laboratory-scale batch assays [194]
Sulfamethoxazole and sulfacetamide Synthetic media
Algae
Lessonia nigrescens Bory
Macrocystis integrifolia Bory
Adsorption Laboratory-scale batch assays [211]
Penicillin G Synthetic media FungiRhizopus arrhizus Biosorption Laboratory-scale batch assays [211]
Chloramphenicol, acetyl salicylic acid, clofibric acid Synthetic media
Algae
Pterocladia capillacea
Ulva lactuca
Biosorption Laboratory-scale batch assays [225]
Paracetamol Synthetic media AlgaeAlga Synechocystis sp. Biosorption
Laboratory-scale batch assays
Pilot-scale continuous
bubbling column
photobioreactor
(continuous feed)
[226]
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4. Conclusions and Future Perspectives
The urban wastewater treatment industry is facing challenges, such as the fate of pharmaceuticals,
which induce the development of wastewater treatment alternatives. In this review, an overview was
drawn of fungi and algae potential to remove pharmaceuticals by bioremediation and biosorption
processes from aquatic matrices. Algae present interesting advantages when compared with fungi,
as they have a very fast growth and are able to remove both pharmaceuticals and nutrients, which is
quite important since tertiary treatments are often needed for this purpose in domestic wastewater
treatment. Moreover, this biomass is a valuable bioresource for the production of biofuel or high-value
by-products. Bioremediation and biosorption studies proved to be eco-friendly and low-cost promising
alternatives for pharmaceutical removal when compared to conventional methods applied for the
same purpose. However, most of these studies remain at a laboratory-scale and are performed with
synthetic media when it is well known that wastewaters are complex matrices that differ between
WWTPs and can vary per geographical region. Only a few researchers are working on real field
applications, since extensive research is still needed in order to understand the complexity of the
processes, their dependence on physico-chemical and biological factors, and the mechanisms involved,
in order to ensure high efficiencies for pharmaceutical removal. New knowledge in genetic engineering
should be introduced in order to select and amplify the most effective algae or fungi strains for
pharmaceutical removal. Several microorganisms contain key metabolic genes that could be introduced
into other organisms. Genetically modified fungi and algae, armed with new or increased capacities
for degrading various compounds, will likely have an important future in this field since it will allow
these microorganisms to effectively remove pharmaceuticals from wastewaters and also allow their
continuous use, considering legal limitations, as well as a pragmatic market and cost rationale.
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